cholesteryl sulfate has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, W; Kim, HJ; Kim, N; Kwon, M; Lee, GR; Lee, HI; Lee, J; Lee, MO; Park, JH | 1 |
1 other study(ies) available for cholesteryl sulfate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Cholesterol sulfate inhibits osteoclast differentiation and survival by regulating the AMPK-Sirt1-NF-κB pathway.
Topics: AMP-Activated Protein Kinases; Animals; Bone Resorption; Cell Differentiation; Cholesterol Esters; Female; Mice; NF-kappa B; Osteoclasts; Osteogenesis; RANK Ligand; Sirtuin 1 | 2023 |